TRADING UPDATES: Baron Oil boosts P2478 stake amid Upland farmout pact
TRADING UPDATES: Baron Oil boosts P2478 stake amid Upland farmout pact
Read moreMon, 08th Oct 2018 09:29
TRADING UPDATES: Baron Oil boosts P2478 stake amid Upland farmout pact
Read moreTRADING UPDATES: Strong annual results from Springfield, Fiske
Read moreIN BRIEF: Diurnal's Efmody adrenal treatment launches in UK
Read moreUK earnings, trading statements calendar - next 7 days
Read moreTRADING UPDATES: Power Metal hits "bullseye"; Instem makes acquisition
Read moreTRADING UPDATES: United Oil & Gas in North Sea sale; Trifast confident
Read more(Sharecast News) - Specialty pharmaceutical company Diurnal announced on Monday that the US Food and Drug Administration (FDA) has agreed a special protocol assessment (SPA) for 'Chronocort', or modified-release hydrocortisone, for the design, endpoints and statistical analysis approach of a pivotal study of the product, for the treatment for congenital adrenal hyperplasia (CAH).
Read more(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced on Friday that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted a marketing authorisation for 'Efmody', or hydrocortisone modified-release hard capsules, as treatment for adult and adolescent patients with the rare congenital adrenal hyperplasia (CAH) condition.
Read moreDiurnal gets UK approval for Efmody drug following EU authorisation
Read moreTRADING UPDATES: Gaming Realms BetMGM deal; Argo bitcoin-backed loan
Read moreTRADING UPDATES: CML plans AIM move; IronRidge to demerge gold assets
Read moreTRADING UPDATES: Odyssean IT swings to profit; BMO Cap ups dividend
Read moreIN BRIEF: Diurnal extends Citrine licensing deal for Efmody in China
Read moreIN BRIEF: Diurnal gets another patent for adrenal insufficiency asset
Read more(Sharecast News) - Hormonal disease-focussed speciality pharmaceutical company Diurnal Group announced the grant of a patent for 'Alkindi', or hydrocortisone granules in capsules for opening, by the European Patent Office on Friday.
Read more